Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Holography of particles for diagnostics tasks [Invited].
Dyomin V, Gribenyukov A, Davydova A, Zinoviev M, Olshukov A, Podzyvalov S, Polovtsev I, Yudin N. Dyomin V, et al. Appl Opt. 2019 Dec 1;58(34):G300-G310. doi: 10.1364/AO.58.00G300. Appl Opt. 2019. PMID: 31873514
Stage I Breast Cancer in the Modern Era: A Retrospective Cohort Study of 328 Patients Diagnosed from 2002 to 2006 with a 14- year Median Follow-Up.
Hadar M, Friger M, Ariad S, Koretz M, Delgado B, Tokar M, Bayme M, Agassi R, Rosenthal M, Dyomin V, Belochitski O, Amir N, Libson S, Meirovitz A, Lazarev I, Abu-Ghanem S, Geffen DB. Hadar M, et al. Among authors: dyomin v. Oncology. 2024 Jan 5. doi: 10.1159/000536119. Online ahead of print. Oncology. 2024. PMID: 38185110
Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy.
Nguyen R, Doubrovina E, Mousset CM, Jin BY, Okada R, Zhang X, Clavel A, Reyes-Gonzalez JM, Dyomin V, Diaz L, Zhang L, Abbas S, Sun M, Hsieh CM, Ho M, Shern JF, Gulley JL, Hinrichs CS. Nguyen R, et al. Among authors: dyomin v. Clin Cancer Res. 2024 Apr 15;30(8):1555-1566. doi: 10.1158/1078-0432.CCR-23-1872. Clin Cancer Res. 2024. PMID: 37910044
Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years.
Dredze LM, Friger M, Ariad S, Koretz M, Delgado B, Shaco-Levy R, Tokar M, Bayme M, Agassi R, Rosenthal M, Dyomin V, Belochitski O, Libson S, Mizrahi T, Geffen DB. Dredze LM, et al. Among authors: dyomin v. Breast Cancer Res Treat. 2022 Jun;193(3):597-612. doi: 10.1007/s10549-022-06598-0. Epub 2022 Apr 22. Breast Cancer Res Treat. 2022. PMID: 35451732
32 results